Skip to main content
Caplight Logo









Elarex Inc.

Elarex Inc.

Private
BurlingtonHealthcare & Life Scienceshttps://elarexinc.com/

Last Round

Grant

Sep 1, 2022

Total Funding Raised

$1.08M

Company Overview

Elarex Inc. is a biotechnology company that develops proprietary stabilization technology to improve the temperature stability of vaccines and biologic drugs, aiming to eliminate the need for cold-chain transportation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

cold chainvaccine stabilizationbiologic drug storageroom temperature storagemRNA therapeuticsbiotech formulationpharma supply chaindrug delivery technologythermostable vaccinescold chain logisticsbiotech licensingLNP therapeuticslast mile deliverycold chain breakagebiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elarex Inc. Comparables

Compare Elarex Inc. with similar companies based on industry and business-model similarity.

Elarex Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Inaedis Inc.
88%
EnsiliTech
87%
Jurata Thin Film
87%

Elarex Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2022
GrantNov 4, 2021

Elarex Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors grew 9511% MoM, from 9 to 865.

  • Dec 4, 2023

    Grew 43% QoQ, from 7 to 10 employees.

Elarex Inc. Filings

Explore SEC and related filing metadata, where available.

Elarex Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Elarex Inc.'s valuation, stock price, and market status.

Is Elarex Inc. a public or private company?

Elarex Inc. is a private company.

What is the current stock price of Elarex Inc.?

Elarex Inc. is a private company with no public stock price. Caplight tracks Elarex Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Elarex Inc. worth (valuation)?

Valuation information for Elarex Inc. is not publicly available.

Can I buy Elarex Inc. stock?

Elarex Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Elarex Inc.'s last funding round?

Elarex Inc.'s most recent funding round was Grant on September 1, 2022.

Who are the main investors in Elarex Inc.?

Key investors in Elarex Inc. include Gates Foundation, National Research Council Canada Industrial Research Assistance Program, National Research Council of Canada, Ontario Centre of Innovation.

Will Elarex Inc. IPO soon?

No public IPO plans have been announced for Elarex Inc..

How can I track Elarex Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Elarex Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBurlington
Employee Range5
Year Founded2019
Last FundingSep 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?